Skip to main content

biGENIUS receives 2 million euros for new cloud product

| News

biGENIUS receives 2 million euros for new cloud product

03.10.2023

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following the release of biGENIUS-X. The new cloud solution for analytical data automation is able to adapt to changing data landscapes.

The team of biGENIUS (image: website biGENIUS)

biGENIUS has secured fresh investment of 2 million euros, as the software firm from Pratteln in the canton of Basel-Landschaft writes in a press release. The financing comes of the back of the release of a new solution for analytical data automation. “As a new product, we can design biGENIUS-X to effectively adapt to the ever-changing data landscape”, comments Thomas Gassmann, Chief Technology Officer of biGENIUS, in the press release. “We have developed a solution geared toward data engineers, with innovative features to help data teams manage the increasing volume and complexity of data”, he adds.

biGENIUS AG was founded in 2021 as a spin-off from the IT service provider Trivadis, which is based in Glattbrugg in the canton of Zurich and has since been taken over by Accenture. The startup from Pratteln specializes in the development of analytical data automation solutions. The company explains in the press release that the new biGENIUS-X solution was developed independently of the established Windows application biGENIUS 7, which has been available since 2011.

New CEO on board

In the same press release, biGENIUS also communicates a change at board level. Accordingly, Gerald Klump was appointed as the new CEO with effect from October 2. The former co-CEO of Trivadis, who was later the Managing Director of Accenture DACH, succeeds Gregor Zeiler as CEO of biGENIUS.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence. The goal...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Do you have a question? We'd like to hear from you.